S1 Clinical Trials
4 recruitingDrug
Phase 24
Showing 1–4 of 4 trials
Recruiting
Phase 2
Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital52 enrolled1 locationNCT07038629
Recruiting
Phase 2
Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)
Adenocarcinoma of the StomachAdenocarcinoma of Esophagogastric JunctionProficient Mismatch Repair
Yu jiren314 enrolled5 locationsNCT05872685
Recruiting
Phase 2
Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
Mismatch Repair DeficiencyAdenocarcinoma of the StomachAdenocarcinoma of Esophagogastric Junction
Yu jiren90 enrolled8 locationsNCT05729646
Recruiting
Phase 2
A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer
Serplulimab,Gastric Cancer, Adjuvant Therapy
RenJi Hospital70 enrolled1 locationNCT05769725